Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization

被引:11
|
作者
Choi, Seung Joon [1 ]
Kim, Jonghoon [2 ]
Seo, Jongbum [3 ]
Kim, Hyung Sik [1 ]
Lee, Jong-min [4 ]
Park, Hyunjin [2 ]
机构
[1] Gachon Univ, Gil Hosp, Dept Radiol, Inchon, South Korea
[2] Sungkyunkwan Univ, Sch Elect & Elect Engn, Suwon, South Korea
[3] Yonsei Univ, Dept Biomed Engn, Wonju, South Korea
[4] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea
来源
ABDOMINAL IMAGING | 2014年 / 39卷 / 03期
基金
新加坡国家研究基金会;
关键词
Hepatocellular carcinoma; Parametric response mapping; Automatic classifier; Transcatheter arterial chemoembolization; Dynamic CT; Longitudinal exam; TRANSARTERIAL CHEMOEMBOLIZATION; LIPIODOL-CHEMOEMBOLIZATION; EMBOLIZATION; THERAPY; MAP; LIVER; RECURRENCES; COMBINATION; MANAGEMENT; SORAFENIB;
D O I
10.1007/s00261-014-0087-z
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Accurate assessment of viability of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) is important for therapy planning. The purpose of this study is to determine the diagnostic value of a novel image analysis method called parametric response mapping (PRM) in predicting viability of tumor in HCC treated with TACE for dynamic CT images. 35 patients who had 35 iodized-oil defect areas (IODAs) in HCCs treated with TACE were included in our study. These patients were divided into two groups, one group with viable tumors (n = 22) and the other group with non-viable tumors (n = 13) in the IODA. All patients were followed up using triple-phase dynamic CT after the treatment. We compared (a) manual analysis, (b) using PRM results, and (c) using PRM results with automatic classifier to distinguish between two tumor groups based on dynamic CT images from two longitudinal exams. Two radiologists performed the manual analysis. The PRM approach was implemented using prototype software. We adopted an off-the-shelf k nearest neighbor (kNN) classifier and leave-one-out cross-validation for the third approach. The area under the curve (AUC) values were compared for three approaches. Manual analysis yielded AUC of 0.74, using PRM results yielded AUC of 0.84, and using PRM results with an automatic classifier yielded AUC of 0.87. We improved upon the standard manual analysis approach by adopting a novel image analysis method of PRM combined with an automatic classifier.
引用
收藏
页码:518 / 525
页数:8
相关论文
共 50 条
  • [41] Hepatocellular carcinoma associated with budd-chiari syndrome: imaging features and transcatheter arterial chemoembolization
    Liu, Feng-Yong
    Wang, Mao-Qiang
    Duan, Feng
    Fan, Qing-Sheng
    Song, Peng
    Wang, Yan
    BMC GASTROENTEROLOGY, 2013, 13
  • [42] Hepatocellular carcinoma associated with budd-chiari syndrome: imaging features and transcatheter arterial chemoembolization
    Feng-Yong Liu
    Mao-Qiang Wang
    Feng Duan
    Qing-Sheng Fan
    Peng Song
    Yan Wang
    BMC Gastroenterology, 13
  • [43] Change in Imaging Findings on Angiography-Assisted CT During Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
    Yoshimatsu, Rika
    Yamagami, Takuji
    Ishikawa, Masaki
    Kajiwara, Kenji
    Aikata, Hiroshi
    Chayama, Kazuaki
    Awai, Kazuo
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2016, 39 (06) : 865 - 874
  • [44] Change in Imaging Findings on Angiography-Assisted CT During Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
    Rika Yoshimatsu
    Takuji Yamagami
    Masaki Ishikawa
    Kenji Kajiwara
    Hiroshi Aikata
    Kazuaki Chayama
    Kazuo Awai
    CardioVascular and Interventional Radiology, 2016, 39 : 865 - 874
  • [45] Durable complete response is achieved by balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma
    Shirono, Tomotake
    Iwamoto, Hideki
    Niizeki, Takashi
    Shimose, Shigeo
    Kajiwara, Akira
    Suzuki, Hiroyuki
    Kamachi, Naoki
    Noda, Yu
    Okamura, Shusuke
    Nakano, Masahito
    Kuromatsu, Ryoko
    Murotani, Kenta
    Koga, Hironori
    Torimura, Takuji
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (09) : 2594 - 2604
  • [46] Apparent Diffusion Coefficient Can Predict Therapy Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization
    Drewes, Ralph
    Heinze, Constanze
    Pech, Maciej
    Powerski, Maciej
    Woidacki, Katja
    Wienke, Andreas
    Surov, Alexey
    Omari, Jazan
    DIGESTIVE DISEASES, 2022, 40 (05) : 596 - 606
  • [47] radiologic response to transcatheter hepatic arterial chemoembolization in hepatocellular carcinoma predicts patient survival times
    Kim, YongSung
    Kim, Hong Joo
    Cho, Yong Kyun
    Kim, Byung Ik
    HEPATOLOGY, 2012, 56 : 447A - 447A
  • [48] Influencing factors related to transcatheter arterial chemoembolization for hepatocellular carcinoma patients achieved tumor response
    Shao, Hongyan
    Deng, Juan
    Xie, Luping
    Zheng, Qiwen
    Zou, Bihui
    Deng, Jun
    Zhang, Tianqi
    He, Jingjing
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (02) : 560 - 566
  • [49] Prognostic factors of hepatocellular carcinoma patients with portal vein tumor thrombosis treated with transcatheter arterial chemoembolization
    Liang, Hongyuan
    Cui, Peng
    Guo, Qiyong
    Mao, Xiaonan
    Wen, Feng
    Sun, Wei
    Shan, Ming
    Lu, Zaiming
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (05) : E331 - E341
  • [50] Cerebral lipiodol embolism following abdomen trauma in a patient with hepatocellular carcinoma treated with transcatheter arterial chemoembolization
    Nie, Quanmin
    Wu, Hao
    Guo, Pin
    Ge, Jianwei
    Qiu, Yongming
    ACTA NEUROLOGICA BELGICA, 2015, 115 (03) : 459 - 461